Growth Metrics

KalVista Pharmaceuticals (KALV) Other Non-Current Assets (2016 - 2024)

Historic Other Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $1.4 million.

  • KalVista Pharmaceuticals' Other Non-Current Assets changed N/A to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $567000.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, KalVista Pharmaceuticals' Other Non-Current Assets stood at $1.4 million.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non-Current Assets peaked at $1.4 million during Q4 2024, and registered a low of $106000.0 during Q3 2023.
  • For the 4-year period, KalVista Pharmaceuticals' Other Non-Current Assets averaged around $411750.0, with its median value being $259000.0 (2021).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first changed by 0.0% in 2020, then soared by 47075.47% in 2024.
  • Quarter analysis of 4 years shows KalVista Pharmaceuticals' Other Non-Current Assets stood at $178000.0 in 2020, then rose by 1.69% to $181000.0 in 2021, then skyrocketed by 86.19% to $337000.0 in 2023, then skyrocketed by 309.2% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q4 2024, $662000.0 for Q4 2024, and $605000.0 during Q3 2024.